Stomach Carcinoma in Situ disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MalaCards based summary: Stomach Carcinoma in Situ, also known as carcinoma in situ of stomach, is related to esophagus carcinoma in situ and lip carcinoma in situ. An important gene associated with Stomach Carcinoma in Situ is CRLF1 (Cytokine Receptor Like Factor 1). Affiliated tissues include liver and bone.

Related Diseases for Stomach Carcinoma in Situ

Sources:
²⁰GeneAnalytics, ²¹GeneCards
See all MalaCards sources

Diseases in the Familial Stomach Cancer family:

stomach carcinoma in situ

Diseases related to Stomach Carcinoma in Situ via text searches within MalaCards or GeneCards Suite gene sharing:

id	Related Disease	Score	Top Affiliating Genes
1	esophagus carcinoma in situ	10.4
2	lip carcinoma in situ	10.2
3	xeroderma of eyelid	9.5	CRLF1, GLS2

Symptoms & Phenotypes for Stomach Carcinoma in Situ

Drugs & Therapeutics for Stomach Carcinoma in Situ

Sources:
¹BitterDB, ⁴ClinicalTrials, ¹⁰DGIdb, ¹⁴DrugBank, ²⁹HMDB, ³³IUPHAR, ⁵⁰Novoseek, ⁵⁶PharmGKB
See all MalaCards sources

Drugs for Stomach Carcinoma in Situ (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 40)

id

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Fentanyl

approved, illicit, investigational, vet_approved

Phase 3

773

437-38-7

3345

Synonyms:

1-Phenethyl-4-(N-phenylpropionamido)piperidine

1-Phenethyl-4-N-propionylanilinopiperidine

1-phenethyl-4-N-propionylanilinopiperidine

437-38-7

5-22-08-00049 (Beilstein Handbook Reference)

80832-90-2

990-73-8 (citrate)

AC1L1FQ2

Actiq

BIDD:GT0555

BRN 0494484

CHEBI:119915

CHEMBL596

CID3345

D00320

DB00813

Duragesic

Duragesic (TN)

Duragesic-100

Duragesic-12

Duragesic-25

Duragesic-50

Duragesic-75

Durogesic

EINECS 207-113-6

Fentanest

Fentanil

Fentanil [DCIT]

Fentanila

Fentanila [INN-Spanish]

Fentanilo

Fentanyl

Fentanyl (JAN/USAN/INN)

Fentanyl CII

Fentanyl [INN:BAN]

Fentanyl citrate

Fentanyl-100

Fentanyl-12

Fentanyl-25

Fentanyl-50

Fentanyl-75

Fentanylum

Fentanylum [INN-Latin]

HSDB 3329

IONSYS

JNS020QD

L001275

LS-124439

Matrifen

MolPort-003-847-369

N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide

N-(1-Phenethyl-4-piperidyl)propionanilide

N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide

N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide

N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide

N-(1-phenethyl-4-piperidyl)propionanilide

N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide

N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide

N-Phenethyl-4-(N-propionylanilino)piperidine

N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide

N-phenethyl-4-(N-propionylanilino)piperidine

N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide

N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide

NCGC00168252-01

Nasalfent

Oprea1_152073

Oprea1_207148

PDSP1_000860

PDSP2_000846

Pentanyl

Phentanyl

Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)

R 4263

Rapinyl

Sentonil

Sublimase

Sublimaze

UNII-UF599785JZ

fentanyl

2

Liver Extracts

Phase 3

3868

3

Narcotics

Phase 3

3486

4

Peripheral Nervous System Agents

Phase 3

22776

5

Adjuvants, Anesthesia

Phase 3

1588

6

Central Nervous System Depressants

Phase 3

12806

7

pancreatic polypeptide

Phase 3

20

8

Analgesics

Phase 3

11287

9

Anesthetics

Phase 3

9001

10

Analgesics, Opioid

Phase 3

3091

11

Anesthetics, General

Phase 3

2787

12

Anesthetics, Intravenous

Phase 3

2406

13

Cola

Nutraceutical

Phase 3

1881

14

Oxaliplatin

approved, investigational

Phase 1, Phase 2

1412

61825-94-3

5310940, 9887054, 43805, 6857599, 9887054

Synonyms:

CHEMBL1201055

CID9887054

D01790

DACPLAT

Diaminocyclohexane Oxalatoplatinum

Eloxatin

Eloxatin (TN)

Elplat

Foloxatine

L-OHP

Oxalatoplatin

Oxalatoplatinum

Oxaliplatin (JAN/USAN/INN)

Oxaliplatin [Usan:Inn:Ban]

Oxaliplatino [Spanish]

Oxaliplatinum [Latin]

Oxaloplatine [French]

Oxaloplatino [Spanish]

Transplatin

oxaliplatin

oxaliplatine

oxaliplatino

oxaliplatinum

15

Levoleucovorin

approved

Phase 1, Phase 2

711

68538-85-2

Synonyms:

(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid

(6S)-5-formyltetrahydrofolic acid

(6S)-Folinic acid

(6S)-Leucovorin

(S)-Leucovorin

Citrovorum factor

L-Folinic acid

Levofolene

Levofolinic acid

N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid

16

leucovorin

approved

Phase 1, Phase 2

1089

58-05-9

143, 54575

Synonyms:

(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate

(6R,S)-5-Formyltetrahydrofolate

10-Formyl-7,8-dihydrofolate

10-Formyl-7,8-dihydrofolic acid

5-Formyl-5,6,7,8-tetrahydrofolate

5-Formyl-5,6,7,8-tetrahydrofolic acid

5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid

5-Formyltetrahydrofolate

5-Formyltetrahydrofolic acid

5-Formyltetrahydropteroylglutamate

5-Formyltetrahydropteroylglutamic acid

5-formyltetrahydrofolic acid

Acide folinique

Calcium citrovorum factor

Calcium folinate

Citrovorum factor

Folinate

Folinic acid

Folinic acid calcium salt

Folinic acid calcium salt USP27

Folinic acid-SF

L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid

L-Leucovorin

L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid

L-leucovorin

Leucal

Leucovorin calcium

Leucovorin folinic acid

Leucovorinum

Leukovorin

Levoleucovorin

N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid

N5-Formyl-5,6,7,8-tetrahydrofolate

N5-Formyl-5,6,7,8-tetrahydrofolic acid

N5-Formyltetrahydrofolate

N5-Formyltetrahydrofolic acid

Welcovorin

Wellcovorin

folinate

17

Fluorouracil

approved

Phase 1, Phase 2

1791

51-21-8

3385

Synonyms:

1-fluoro-1h-pyrimidine-2,4-dione

1004-03-1

1upf

2,4-Dihydroxy-5-fluoropyrimidine

2,4-Dioxo-5-fluoropryimidine

2,4-Dioxo-5-fluoropyrimidine

47576_FLUKA

4921-97-5

5 FU Lederle

5 FU medac

5 Fluorouracil

5 Fluorouracil biosyn

5 HU Hexal

5-FU

5-FU (TN)

5-FU Lederle

5-FU medac

5-Faracil

5-Fluor-2,4(1H,3H)-pyrimidindion

5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]

5-Fluor-2,4-dihydroxypyrimidin

5-Fluor-2,4-dihydroxypyrimidin [Czech]

5-Fluor-2,4-pyrimidindiol

5-Fluor-2,4-pyrimidindiol [Czech]

5-Fluoracil

5-Fluoracil [German]

5-Fluoracyl

5-Fluoro-2,4(1H,3H)-pyrimidinedione

5-Fluoro-2,4-pyrimidinedione

5-Fluoropyrimidin-2,4-diol

5-Fluoropyrimidine-2,4-dione

5-Fluorouracil

5-Fluorouracil-biosyn

5-Fluoruracil

5-Fluoruracil [German]

5-Fluracil

5-Ftouracyl

5-HU Hexal

5-fluoro uracil

5-fluoro-1H-pyrimidine-2,4-dione

5-fluoropyrimidine-2,4(1H,3H)-dione

5-fluorouracil

51-21-8

5FU

79108-01-3

AC-11201

AC1L1FTE

AC1Q4N2X

AI3-25297

AKOS000119162

AKOS003237897

AccuSite

Actino-Hermal

Adrucil

Adrucil (TN)

Allergan Brand of Fluorouracil

Arumel

BB_NC-0576

BSPBio_002048

C07649

C4H3FN2O2

CCRIS 2582

CHEBI:46345

CHEMBL185

CID3385

CPD0-1327

CPD000038082

CSP Brand of Fluorouracil

Carac

Carac (TN)

Carzonal

Cinco FU

Cytosafe

D005472

D00584

DB00544

Dakota Brand of Fluorouracil

Dakota, Fluorouracile

Dermatech Brand of Fluorouracil

Dermik Brand of Fluorouracil

DivK1c_000054

EINECS 200-085-6

EU-0100536

Effluderm

Effluderm (free base)

Efudex

Efudix

Efurix

F 6627

F0151

F6627_SIGMA

F8423_SIGMA

FT-0082524

FU

Ferrer Brand of Fluorouracil

Fiverocil

Fluoro Uracil

Fluoro Uracile ICN

Fluoro-Uracile ICN

Fluoro-uracile

Fluoro-uracilo

Fluoroblastin

Fluoroplex

Fluoroplex (TN)

Fluorouracil

Fluorouracil (JP15/USP/INN)

Fluorouracil GRY

Fluorouracil Mononitrate

Fluorouracil Monopotassium Salt

Fluorouracil Monosodium Salt

Fluorouracil Potassium Salt

Fluorouracil Teva Brand

Fluorouracil [USAN:INN:BAN:JAN]

Fluorouracil-GRY

Fluorouracile

Fluorouracile Dakota

Fluorouracile [DCIT]

Fluorouracilo

Fluorouracilo Ferrer Far

Fluorouracilo [INN-Spanish]

Fluorouracilum

Fluorouracilum [INN-Latin]

Fluoruracil

Fluouracil

Flurablastin

Fluracedyl

Fluracil

Fluracilum

Fluri

Fluril

Fluro Uracil

Fluroblastin

Flurodex

Flurouracil

Flurox

Ftoruracil

Gry Brand of Fluorouracil

HMS1920O18

HMS2090I04

HMS2091F19

HMS500C16

HSDB 3228

Haemato Brand of Fluorouracil

Haemato fu

Haemato-fu

Hexal Brand of Fluorouracil

I07-0022

ICN Brand of Fluorouracil

IDI1_000054

IN1335

KBio1_000054

KBio2_001321

KBio2_003889

KBio2_006457

KBio3_001268

KBioGR_001253

KBioSS_001321

Kecimeton

LS-153

Lopac-F-6627

Lopac0_000536

MLS000069498

MLS002415705

MolPort-000-156-102

MolPort-003-990-447

MolPort-004-758-143

MolPort-004-758-144

MolPort-005-861-486

NCGC00015442-01

NCGC00015442-03

NCGC00015442-10

NCGC00091349-01

NCGC00091349-02

NCGC00091349-03

NCGC00091349-04

NCGC00091349-05

NCGC00091349-07

NCGC00091349-08

NCI60_001652

NINDS_000054

NSC 19893

NSC-19893

NSC19893

Neocorp Brand of Fluorouracil

Neofluor

Onkofluor

Onkoworks Brand of Fluorouracil

Phthoruracil

Phtoruracil

Queroplex

Ribofluor

Riemser Brand of Fluorouracil

Ro 2-9757

Ro-2-9757

Roche Brand of Fluorouracil

S1209_Selleck

SAM002264615

SMR000038082

SPBio_000291

SPECTRUM1500305

STK297802

Spectrum2_000076

Spectrum3_000434

Spectrum4_000557

Spectrum5_000718

Spectrum_000841

T5233394

TL8006093

Teva Brand of Fluorouracil

Timazin

U 8953

U-8953

UNII-U3P01618RT

UPCMLD-DP130

UPCMLD-DP130:001

URF

Ulup

WLN: T6MVMVJ EF

ZINC00897110

biosyn Brand of Fluorouracil

fluorouracil

inhibits thymilidate synthetase

medac Brand of Fluorouracil

nchembio.90-comp3

nchembio809-comp6

ribosepharm Brand of Fluorouracil

tetratogen

18

Cisplatin

approved

Phase 2

2690

15663-27-1

84093, 441203, 2767

Synonyms:

(SP-4-1)-diamminedichloridoplatinum

(SP-4-1)-diamminedichloroplatinum

(SP-4-2)-diamminedichloridoplatinum

(SP-4-2)-diamminedichloroplatinum

Abiplatin

Biocisplatinum

Briplatin

CACP

CDDP

CHEBI:35852

CID441203

CPD0-1392

CPDC

CPDD

Carboquone

Cis Pt II

Cis-DDP

Cis-Diaminedichloroplatinum

Cis-Diamminedichloroplatinum

Cismaplat

Cisplatine

Cisplatino

Cisplatinum

Cisplatyl

Citoplationo

DB00515

DDP

DDPT

Diamminedichloroplatinum

EU-0100918

Lederplatin

Neoplatin

Peyrone's chloride

Peyrone's salt

Plastin

Platamine

Platiblastin

Platidiam

Platinex

Platinol

Platinol-AQ

Platinoxan

Platinum Ammine Chloride

Platinum Ammonium Chloride

Platinum Diamine Dichloride

Randa

Trans-DDP

Trans-Diaminedichloroplatinum

Trans-Diamminedichloroplatinum

Trans-Dichlorodiammine Platinum

Trans-Platinumdiammine Dichloride

cis-DDP

cis-Diamminedichloroplatinum

cis-Dichlorodiammineplatinum(II)

cis-[PtCl2(NH3)2]

cis-diamminedichloridoplatinum(II)

cis-diamminedichloroplatinum(II)

nchembio773-comp1

trans-diamminedichloridoplatinum(II)

19

Folic Acid

approved, nutraceutical, vet_approved

Phase 1, Phase 2

4279

59-30-3

6037

Synonyms:

(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid

01769_FLUKA

2d0k

33609-88-0

36653-55-1 (mono-potassium salt)

59-30-3

6484-89-5 (mono-hydrochloride salt)

AC-11682

AC1L1LNX

AI3-26387

AKOS000503224

ARONIS014410

Acfol (Spain)

Acide folique

Acide folique [INN-French]

Acido folico

Acido folico [INN-Spanish]

Acidum folicum

Acidum folicum [INN-Latin]

Acifolic

Antianemia factor

Apo-Folic

BIDD:ER0563

BIDD:GT0641

BIF0608

BPBio1_000654

BSPBio_000594

BSPBio_002338

C00504

C20H20N6O6

CAS-59-30-3

CCRIS 666

CHEBI:27470

CHEMBL1622

CID6037

CPD000471860

Cytofol

D00070

DB00158

DivK1c_000494

Dosfolat B activ

EINECS 200-419-0

F0043

F7876_SIAL

F7876_SIGMA

F8758_SIGMA

F8798_SIAL

F8890_SIGMA

FOL

Facid

Factor U

Folacid

Folacin

Folaemin

Folaemin [Netherlands]

Folan

Folasic (Australia)

Folate

Folbal

Folcidin

Folcidin (VAN)

Folcysteine

Foldine

Foldine [France]

Folettes

Foliamin

Folic

Folic acid

Folic acid (JP15/USP/INN)

Folic acid (TN)

Folic acid [BAN:INN:JAN]

Folic acid [INN:BAN:JAN]

Folic acid dihydrate

Folicet

Folicet (TN)

Folico

Folico (Italy)

Folina

Folina (Italy)

Folipac

Folsaeure

Folsan

Folsaure

Folsav

Folvite

Folvron

Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L

HMS1921D20

HMS2092N17

HMS501I16

HSDB 2002

IDI1_000494

InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s

Incafolic

KBio1_000494

KBio2_001861

KBio2_004429

KBio2_006997

KBio3_001558

KBioGR_002222

KBioSS_001861

Kyselina listova

Kyselina listova [Czech]

LS-2157

Liver Lactobacillus casei factor

MLS001304016

MLS001335861

Millafol

Mission prenatal

Mittafol

MolPort-004-285-551

N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid

N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid

N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid

N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid

N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid

N-Pteroyl-L-glutamic acid

N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid

N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid

N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid

NCGC00016265-01

NCGC00142391-01

NINDS_000494

NSC 3073

Nifolin

Nifolin [Denmark]

Novofolacid

Novofolacid [Canada]

PGA

PGA (VAN)

Prestwick3_000627

Prestwick_230

PteGlu

Pteroyl-L-glutamate

Pteroyl-L-glutamic acid

Pteroyl-L-monoglutamate

Pteroyl-L-monoglutamic acid

Pteroylglutamate

Pteroylglutamic acid

Pteroylmonoglutamate

Pteroylmonoglutamic acid

SAM002264616

SDCCGMLS-0066738.P001

SMP2_000137

SMR000471860

SPBio_001357

SPECTRUM1502020

Serum Folate Level

Spectrum2_001459

Spectrum3_000749

Spectrum4_001751

Spectrum5_000602

Spectrum_001381

UNII-935E97BOY8

Usaf cb-13

Vitamin B11

Vitamin B9

Vitamin Bc

Vitamin Be

Vitamin M

bmse000299

folic acid

nchembio.108-comp10

20

Trace Elements

Phase 1, Phase 2

5802

21

Vitamin B Complex

Phase 1, Phase 2

4229

22

Protective Agents

Phase 1, Phase 2

7190

23

Micronutrients

Phase 1, Phase 2

5802

24

Antimetabolites

Phase 1, Phase 2

11774

25

Vitamins

Phase 1, Phase 2

5095

26

Antidotes

Phase 1, Phase 2

1038

27

Antimetabolites, Antineoplastic

Phase 1, Phase 2

7171

28

Bone Density Conservation Agents

Phase 1, Phase 2

3266

29

Calcium, Dietary

Phase 1, Phase 2

5525

30

Immunosuppressive Agents

Phase 1, Phase 2

12770

31

Folate

Nutraceutical

Phase 1, Phase 2

4279

32

Folinic Acid

Nutraceutical

Phase 1, Phase 2

3150

33

Vitamin B9

Nutraceutical

Phase 1, Phase 2

4279

34

Immunoglobulins

Phase 1

6045

35

Antibodies

Phase 1

6045

36

Trastuzumab

approved, investigational

766

180288-69-1

9903

Synonyms:

180288-69-1

Anti HER2

Anti-erbB2 Monoclonal Antibody

D03257

HER2 Monoclonal Antibody

Herceptin

Herceptin (TN)

Ig gamma-1 chain C region

Trastuzumab

Trastuzumab (INN)

Trastuzumab (genetical recombination)

Trastuzumab (genetical recombination) (JAN)

trastuzumab

37

Paclitaxel

approved, vet_approved

2758

33069-62-4

36314

Synonyms:

(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

157069-30-2

33069-62-4

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.

7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.

7-Epi-Paclitaxel

7-Epi-Taxol

7-Epipaclitaxel

7-Epitaxol

7-epi-Paclitaxel

7-epi-Taxol

AB00513812

ABI 007

ABI-007

ABI007

AC-675

AC1L1IOG

AC1L1VJI

AC1L9AVF

ACon1_002231

ANX-513

Abraxane

Abraxane (TN)

Abraxane I.V. Suspension

Abraxis BioScience brand of albumin-bound paclitaxel

Ambotz33069-62-4

Anzatax

Asotax

BIDD:PXR0046

BMS 181339-01

BMS-181339

BMS-181339-01

BPBio1_000320

BRD-A23723433-001-01-2

BRD-A28746609-001-04-0

BRD-K62008436-001-03-1

BSPBio_000290

BSPBio_001152

BSPBio_002614

Bio-0076

Bio1_000362

Bio1_000851

Bio1_001340

Bio2_000416

Bio2_000896

Bristaxol

C07394

C466458

C47H51NO14

CCRIS 8143

CHEBI:103439

CHEBI:45863

CHEMBL100910

CHEMBL418410

CHEMBL48

CID36314

CID441276

CID4666

CID6713921

CID6915727

CPD-8718

Capxol

D00491

DB01229

DHP-107

DHP-208

DRG-0190

DTS-301

DivK1c_000441

EU-0101201

Ebetaxel

EmPAC

Epitaxol

Genaxol

Genetaxyl

Genexol

Genexol-PM

HMS1362J13

HMS1568O12

HMS1792J13

HMS1922K08

HMS1990J13

HMS2090D07

HMS2093K15

HMS501G03

HSDB 6839

I06-0014

IDI1_000441

IDI1_002171

Intaxel

KBio1_000441

KBio2_000492

KBio2_002016

KBio2_002509

KBio2_003060

KBio2_004584

KBio2_005077

KBio2_005628

KBio2_007152

KBio2_007645

KBio3_000903

KBio3_000904

KBio3_001834

KBio3_002987

KBioGR_000492

KBioGR_001893

KBioGR_002509

KBioSS_000492

KBioSS_002016

KBioSS_002517

LMPR0104390001

LS-31070

LipoPac

Lopac0_001201

MBT 0206

MEGxp0_001940

MLS000863266

MLS001077297

MLS002154218

MLS002172439

MLS002695976

MPI-5018

Micellar Paclitaxel

Mitotax

MolPort-001-742-627

MolPort-003-665-783

MolPort-003-932-365

NCGC00024995-02

NCGC00024995-03

NCGC00024995-04

NCGC00024995-05

NCGC00024995-06

NCGC00024995-07

NCGC00164367-01

NCGC00164367-02

NCGC00164367-03

NCI60_000601

NINDS_000441

NK 105

NP-010981

NSC 125973

NSC-125973

NSC125973

NSC358882

Nanotaxel

Neuro_000060

Nova-12005

OAS-PAC-100

OncoGel

Onxal

Onxol

Onxol, Taxol, Nov-Onxol, Paclitaxel

P1632

Paclical

Pacligel

Paclitaxel

Paclitaxel (JAN/USP)

Paclitaxel (JAN/USP/INN)

Paclitaxel (Taxol)

Paclitaxel [USAN:INN:BAN]

Paxceed

Paxene

Paxoral

Plaxicel

Praxel

Prestwick0_000155

Prestwick1_000155

Prestwick2_000155

Prestwick3_000155

Probes2_000350

QW 8184

S-8184 Paclitaxel Injectable Emulsion

S1150_Selleck

SDCCGMLS-0066823.P001

SDP-013

SMP1_000228

SMR000394086

SMR000857385

SPBio_000943

SPBio_002229

SPECTRUM1503908

ST50306996

Spectrum2_000872

Spectrum3_001057

Spectrum4_001197

Spectrum5_001491

Spectrum_001536

T 7402

T1912_SIGMA

T7191_SIGMA

T7402_SIGMA

TA1

TAXOL (TN)

TAXOL, 10-EPI,

TXL

TaxAlbin

Taxol

Taxol A

Taxol Konzentrat

Taxol.RTM. (Registered Trademark)

UNII-P88XT4IS4D

UPCMLD-DP108:001

UPCMLD-DP108:002

Vascular Wrap

Xorane

Yewtaxan

abi-007

albumin-bound paclitaxel

cMAP_000068

nab-paclitaxel

nchembio.188-comp1

nchembio.2007.34-comp9

nchembio.215-comp9

nchembio853-comp6

paclitaxel

weekly paclitaxel

38

nivolumab

approved

326

946414-94-4

Synonyms:

BMS-936558

MDX-1106

ONO-4538

nivolumab

39

Mitogens

1526

40

Albumin-Bound Paclitaxel

2757

Interventional clinical trials:

(show all 17)

id	Name	Status	NCT ID	Phase
1	Difference of Gastric Microbiota in the Process of Correa's Model.	Recruiting	NCT02833363	Phase 4
2	Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain	Completed	NCT00538850	Phase 3
3	C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer	Unknown status	NCT02344810	Phase 1, Phase 2
4	A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients	Recruiting	NCT01100801	Phase 2
5	A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression	Recruiting	NCT02512237	Phase 1
6	Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma	Unknown status	NCT02002416
7	Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma	Unknown status	NCT01642797
8	Clinical Relevance of ROS (V-ros UR2 Sarcoma Virus Oncogene Homolog) Aberrations in Solid Tumours	Unknown status	NCT01596374
9	Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma	Completed	NCT02731313
10	Trastuzumab Based Therapy in HER2 Positive AGC	Completed	NCT03024450
11	Biomarker-Integrated Umbrella, Advanced Gastric Cancer	Recruiting	NCT02951091
12	Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer	Recruiting	NCT02610218
13	PCLE for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma	Recruiting	NCT02515721
14	Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN)	Recruiting	NCT01104077
15	Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients	Recruiting	NCT01877135
16	Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus	Terminated	NCT00386594
17	Esophageal Cytology With FISH in Detecting Esophageal Cancer in Participants Undergoing Esophago-Gastro-Duodenoscopy or Upper Endoscopy.	Terminated	NCT02100189